Fesoterodine Dose Response in Subjects With Overactive Bladder Syndrome von Khullar, Vik, Rovner, Eric S, Dmochowski, Roger, Nitti, Victor, Wang, Joseph, Guan, Zhonghong

Volltext

Efficacy and Tolerability of Fesoterodine in Men With Overactive Bladder: A Pooled Analysis of 2 Phase III Studies von Herschorn, Sender, Jones, J. Stephen, Oelke, Matthias, MacDiarmid, Scott, Wang, Joseph T, Guan, Zhonghong

Volltext

Tolterodine and Tamsulosin for Treatment of Men With Lower Urinary Tract Symptoms and Overactive Bladder: A Randomized Controlled Trial von Kaplan, Steven A, Roehrborn, Claus G, Rovner, Eric S, Carlsson, Martin, Bavendam, Tamara, Guan, Zhonghong

Volltext

Re: Claus G. Roehrborn, Steven A. Kaplan, J. Stephen Jones, Joseph T. Wang, Tamara Bavendam, Zhonghong Guan. Tolterodine Extended Release With or Without Tamsulosin in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms: Effects of Prostate Size. Eur Urol 2009;55:472–81 von Chung, Shiu-Dong, Chiu, Bin, Chuang, Yao-Chi, Kuo, Hann-Chorng

Volltext

Fesoterodine in patients with overactive bladder syndrome: can the severity of baseline urgency urinary incontinence predict dosing requirement? von Cardozo, Linda, Khullar, Vik, Wang, Joseph T., Guan, Zhonghong, Sand, Peter K.

Volltext

Tolterodine Treatment Improves Storage Symptoms Suggestive of Overactive Bladder in Men Treated With α-Blockers von Chapple, Christopher, Herschorn, Sender, Abrams, Paul, Sun, Franklin, Brodsky, Marina, Guan, Zhonghong

Volltext

Add‐on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α‐blocker treatment for lower urinary tract symptoms von Kaplan, Steven A., Roehrborn, Claus G., Gong, Jason, Sun, Franklin, Guan, Zhonghong

Volltext

Superior efficacy of fesoterodine over tolterodine extended release with rapid onset: a prospective, head‐to‐head, placebo‐controlled trial von Kaplan, Steven A., Schneider, Tim, Foote, Jenelle E., Guan, Zhonghong, Carlsson, Martin, Gong, Jason

Volltext

Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head‐to‐head placebo‐controlled trial von Herschorn, Sender, Swift, Steven, Guan, Zhonghong, Carlsson, Martin, Morrow, Jon D., Brodsky, Marina, Gong, Jason

Volltext

Dynamic Progression of Overactive Bladder and Urinary Incontinence Symptoms: A Systematic Review von Irwin, Debra E, Milsom, Ian, Chancellor, Michael B, Kopp, Zoe, Guan, Zhonghong

Volltext

Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder von Dmochowski, Roger R, Peters, Kenneth M, Morrow, Jon D, Guan, Zhonghong, Gong, Jason, Sun, Franklin, Siami, Paul, Staskin, David R

Volltext

Achieving continence with antimuscarinic therapy for overactive bladder: effects of baseline incontinence severity and bladder diary duration von Wein, Alan J., Khullar, Vik, Wang, Joseph T., Guan, Zhonghong

Volltext

The clinical efficacy of tolterodine extended‐release is maintained for 24 h in patients with overactive bladder von Dmochowski, Roger, Kreder, Karl, MacDiarmid, Scott, Carlsson, Martin, Guan, Zhonghong

Volltext

Extended‐release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International P... von Kaplan, Steven A., Roehrborn, Claus G., Chancellor, Michael, Carlsson, Martin, Bavendam, Tamara, Guan, Zhonghong

Volltext

Long-Term Safety, Tolerability and Efficacy of Fesoterodine in Subjects with Overactive Bladder Symptoms Stratified by Age: Pooled Analysis of Two Open-Label Extension Studies von Sand, Peter K., Heesakkers, John, Kraus, Stephen R., Carlsson, Martin, Guan, Zhonghong, Berriman, Sandra

Volltext

Efficacy and safety of tolterodine extended‐release in men with overactive bladder symptoms treated with an α‐blocker: effect of baseline prostate‐specific antigen concentration... von Chapple, Christopher R., Herschorn, Sender, Abrams, Paul, Wang, Joseph T., Brodsky, Marina, Guan, Zhonghong

Volltext

Efficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active women von Rogers, Rebecca, Bachmann, Gloria, Jumadilova, Zhanna, Sun, Franklin, Morrow, Jon D., Guan, Zhonghong, Bavendam, Tamara

Volltext

Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia von Kaplan, Steven A., Roehrborn, Claus G., Dmochowski, Roger, Rovner, Eric S., Wang, Joseph T., Guan, Zhonghong

Volltext

Induction of Cyclooxygenase-2 by the Activated MEKK1 → SEK1/MKK4 → p38 Mitogen-activated Protein Kinase Pathway von Guan, Zhonghong, Buckman, ShaAvhree Y., Pentland, Alice P., Templeton, Dennis J., Morrison, Aubrey R.

Volltext

Transabdominal ultrasonography of detrusor wall thickness in women with overactive bladder von Chung, Shiu‐Dong, Chiu, Bin, Kuo, Hann‐Chorng, Chuang, Yao‐Chi, Wang, Chung‐Cheng, Guan, Zhonghong, Chancellor, Michael B.

Volltext